Working closely with oncologists on value assessment frameworks can save money for the healthcare system while guaranteeing great outcomes for patients, Steve Miller, MD, senior vice president and chief medical officer of Express Scripts, said during a pre-meeting session of AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016.
Working closely with oncologists on value assessment frameworks can save money for the healthcare system while guaranteeing great outcomes for patients, Steve Miller, MD, senior vice president and chief medical officer of Express Scripts, said during a pre-meeting session of AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016.
Transcript (slightly modified)
Is Express Scripts using any of the value assessment frameworks to aid in formulary decision making?
We already are using value-based concepts. We actually work very close with ICER [Institute of Clinical and Economic Review], we've also been working very closely with Peter Bach, MD, and his DrugAbacus at Memorial Sloan Kettering. And so we look at, there are going to be opportunities to actually narrow formularies in oncology in the near future, which we've never had before. But it's going to take a level of sophistication and cooperation with the oncologists that we've never had before.
How are you working with oncologists to educate them about these new frameworks?
I'll be up at ASCO in just a couple of weeks. We actually view that we have got to have relationships. We've proved with hepatitis that if we have really close working relationships with the hepatologists we could get 96% cure rates and save $1 billion. We believe that same opportunity exists in oncology.
By working closer with the oncologists on care pathways, selection of drugs, introductions of biosimilars and generics for oncologic agents, we're going to be able to find areas where we can save money but also guarantee great outcomes for patients. And that really is the aim of the project.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More